MAGLUMI Anti-HBc (CLIA)
Total antibody to hepatitis B core antigen (anti-HBc) · class IV · Until 11/01/2031
- Registration no.
- 80102512627
- Process no.
- 25351050247202070
- Status
- Until 11/01/2031
- Device type
- Total antibody to hepatitis B core antigen (anti-HBc) (ANTICORPO TOTAL NUCLEAR PARA VÍRUS DE HEPATITE B (ANTI-HBCAG))
- Risk class
- IV
- Registration holder
- VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA CNPJ 04.718.143/0001-94 · 4,180 registrations
- Manufacturer
- Published
- 11/01/2021
- Valid until
- 11/01/2031
- Last updated by ANVISA
- 2026-10-12
- Official record
- View on ANVISA ↗